Genotype-dependent tumor regression in Marek's disease mediated at the level of tumor immunity

Medicine and Dentistry

• Marek Disease 100%
• Tumor Microenvironment 100%
• Tumor Regression 100%
• Tumor Immunity 100%
• Infection 66%
• Cytotoxic T-Cell 66%
• Non-Hodgkin Lymphoma 33%
• Gene Expression 33%
• Lymphocyte 33%
• Gallid Alphaherpesvirus 2 33%
• Transformed Cell 33%
• CTLA-4 33%
• Disease Resistance 33%
• Interleukin 18 33%

Immunology and Microbiology

• Cytotoxic T Cell 100%
• Tumor Immunity 100%
• Gene Expression 50%
• Lymphocyte 50%
• Transformed Cell 50%
• Gallid Alphaherpesvirus 2 50%
• Gene Ontology 50%
• Interleukin 18 50%
• CTLA-4 50%

Keyphrases

• IL-12/IL-18 20%
• Susceptible Lines 20%